Holmen Bob has filed 4 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 19000 shares of Sensei Biotherapeutics, Inc. ($SNSE) on May 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Sensei Biotherapeutics, Inc. | $SNSE | Holmen Bob | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 25,117,238 | 9999.99% | 0.08% |
| June 11, 2024 | Sensei Biotherapeutics, Inc. | $SNSE | Holmen Bob | Not found | A | Stock Option (Right to Buy) | 19000 | $0.00 | 19,000.0000 | 27,952,857 | 9999.99% | 0.07% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Holmen Bob | Director | A | Common Stock | 4466 | $0.00 | 25,598.0000 | 0 | 21.13% | 0.00% |
| July 10, 2023 | Sensei Biotherapeutics, Inc. | $SNSE | Holmen Bob | Director | A | Stock Option (Right to Buy) | 14550 | $0.00 | 14,550.0000 | 0 | 9999.99% | 0.00% |